1. Home
  2. PATK vs IMNM Comparison

PATK vs IMNM Comparison

Compare PATK & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Patrick Industries Inc.

PATK

Patrick Industries Inc.

HOLD

Current Price

$84.50

Market Cap

3.0B

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$22.21

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PATK
IMNM
Founded
1959
2006
Country
United States
United States
Employees
N/A
177
Industry
Auto Parts:O.E.M.
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.5B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
PATK
IMNM
Price
$84.50
$22.21
Analyst Decision
Buy
Strong Buy
Analyst Count
8
10
Target Price
$122.75
$32.80
AVG Volume (30 Days)
918.1K
1.6M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
2.02%
N/A
EPS Growth
N/A
51.40
EPS
1.10
N/A
Revenue
$29,000,000.00
$6,941,000.00
Revenue This Year
$5.78
N/A
Revenue Next Year
$6.51
$1,127.34
P/E Ratio
$77.68
N/A
Revenue Growth
262.50
N/A
52 Week Low
$81.29
$8.67
52 Week High
$148.50
$27.65

Technical Indicators

Market Signals
Indicator
PATK
IMNM
Relative Strength Index (RSI) 44.89 51.66
Support Level $82.49 $19.28
Resistance Level $90.28 $23.25
Average True Range (ATR) 2.70 1.15
MACD 0.17 -0.15
Stochastic Oscillator 39.18 17.01

Price Performance

Historical Comparison
PATK
IMNM

About PATK Patrick Industries Inc.

Patrick Industries Inc is a component solutions provider for the recreational vehicle (RV), marine, powersports, manufactured housing (MH), and various industrial markets, including single and multi-family housing, hospitality, institutional, and commercial markets. The company operates within two reportable segments, Manufacturing and Distribution. The majority of its revenue is generated from the Manufacturing segment, which offers laminated products utilized to produce furniture, shelving, walls, and countertops; fabricated aluminum products; cabinet products, doors, components, and custom cabinetry; interior passage doors and baggage doors; RV and marine furniture, etc. Geographically, the company mainly operates in the United States, with a small presence in Mexico, China, and Canada.

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

Share on Social Networks: